TY  - JOUR

T1  - Cost-effectiveness of lenvatinib compared with sorafenib for the first-line treatment of advanced hepatocellular carcinoma in Australia

JO  - Clinical Drug Investigation

UR  - http://eprints.whiterose.ac.uk/168918/

PY  - 2020/12/01

AU  - Saiyed M

AU  - Byrnes J

AU  - Srivastava T

AU  - Scuffham P

AU  - Downes M

ED  - 

DO  - DOI: 10.1007/s40261-020-00983-7

PB  - Springer Science and Business Media LLC

VL  - 40

IS  - 12

SP  - 1167

EP  - 1176

Y2  - 2024/12/22

ER  -